NCT04094064View on ClinicalTrials.gov

Evaluation of Accuracy of Continuous Glucose Monitoring (CGM) in Patients With End Stage Renal Disease (ESRD) on Intermittent Hemodialysis (iHD).

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

February 19, 2020

Primary Completion Date

September 29, 2021

Study Completion Date

September 29, 2021

Conditions
DiabetesDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2
Interventions
DEVICE

Continuous Glucose Monitor

Use of a continuous glucose monitor during study period.

Trial Locations (1)

22903

Meaghan Stumpf, MD, Charlottesville

All Listed Sponsors
collaborator

DexCom, Inc.

INDUSTRY

lead

University of Virginia

OTHER

NCT04094064 - Evaluation of Accuracy of Continuous Glucose Monitoring (CGM) in Patients With End Stage Renal Disease (ESRD) on Intermittent Hemodialysis (iHD). | Biotech Hunter | Biotech Hunter